Related Experiment Video
Updated: Nov 5, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Store-Operated Calcium Channels as Drug Target in Gastroesophageal Cancers
Yan Chang1, Souvik Roy2, Zui Pan1
1College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, TX, United States.
Abstract:
Gastroesophageal cancers, including tumors occurring in esophagus and stomach, usually have poor prognosis and lack effective chemotherapeutic drugs for treatment. The association between dysregulated store-operated calcium entry (SOCE), a key intracellular Ca2+ signaling pathway and gastroesophageal cancers are emerging. This review summarizes the recent advances in understanding the contribution of SOCE-mediated intracellular Ca2+ signaling to gastroesophageal cancers. It assesses the pathophysiological role of each component in SOCE machinery, such as Orais and STIMs in the cancer cell proliferation, migration, and invasion as well as stemness maintenance. Lastly, it discusses efforts towards development of more specific and potent SOCE inhibitors, which may be a new set of chemotherapeutic drugs appearing at the horizon, to provide either targeted therapy or adjuvant treatment to overcome drug resistance for gastroesophageal cancers.
Insights
Store-operated calcium entry (SOCE) is increasingly linked to gastroesophageal cancers. Targeting SOCE components like Orai and STIM may offer new chemotherapy options for esophageal and stomach cancers.
Area of Science:
- Oncology
- Molecular Biology
- Calcium Signaling
Background:
- Gastroesophageal cancers (esophageal and stomach) have a poor prognosis and limited effective chemotherapies.
- Dysregulated store-operated calcium entry (SOCE), a critical intracellular calcium (Ca2+) pathway, is emerging as a factor in these cancers.
Purpose of the Study:
- To review recent findings on SOCE's role in gastroesophageal cancers.
- To assess the function of SOCE components (Orai, STIM) in cancer progression and stemness.
- To discuss the potential of SOCE inhibitors as novel cancer therapeutics.
Main Methods:
- Literature review of recent advances in SOCE research related to gastroesophageal cancers.
- Analysis of the pathophysiological roles of Orai and STIM proteins in cancer cell behavior.
- Evaluation of current strategies for developing SOCE inhibitors.
Main Results:
- SOCE plays a significant role in the proliferation, migration, invasion, and stemness maintenance of gastroesophageal cancer cells.
- Specific components of the SOCE machinery, including Orai and STIM proteins, are implicated in these cancer processes.
- Development of targeted SOCE inhibitors is a promising area for new cancer treatments.
Conclusions:
- Understanding SOCE's contribution to gastroesophageal cancers is crucial for developing effective therapies.
- Targeting SOCE offers a potential strategy for novel chemotherapeutic drugs, including targeted therapy or adjuvant treatment.
- SOCE inhibitors may help overcome drug resistance in esophageal and stomach cancer treatment.
More Related Videos
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
G-Protein Gated Ion Channels
Sensory...

